Recombinant Vaccines

Recombinant vaccines are a type of vaccine that are developed by combining genetic material from different sources, often from different species. They are designed to provide immunity against a wide range of diseases and other infections. The benefits of recombinant vaccines are that they are more cost-effective, can be produced faster, and are more likely to be accepted by the body. They are increasingly being used in the prevention of various diseases, from influenza to hepatitis, and to help reduce the mortality rate from diseases such as malaria, dengue fever, and HIV/AIDS. Recombinant vaccines are also being developed to protect against emerging pathogens and bioterrorism agents.

← Journal of DNA And RNA Research

Related Articles

3 article(s) found

Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe

Full-text HTML Download PDF Download XML

FDA Should Re-evaluate All mRNA Vaccines and Revoke Their Use Authorizations (The Short Version).

Full-text HTML Download PDF Download XML

Expression of Concern: Potential Risks and Unknown Effects of mRNA Vaccines on Population Health (6th Rev). Damages Are Being Materialized

Full-text HTML Download PDF Download XML